These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25574109)

  • 21. MACC 1 as a marker for peritoneal-disseminated gastric carcinoma.
    Shirahata A; Sakata M; Kitamura Y; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2010 Sep; 30(9):3441-4. PubMed ID: 20944120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer.
    Wang C; Wen Z; Xie J; Zhao Y; Zhao L; Zhang S; Liu Y; Xue Y; Shi M
    Biochem Biophys Res Commun; 2017 Apr; 485(3):665-671. PubMed ID: 28235486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
    Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
    Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1.
    Zhao Y; Liu Y; Lin L; Huang Q; He W; Zhang S; Dong S; Wen Z; Rao J; Liao W; Shi M
    Mol Cancer; 2018 Mar; 17(1):69. PubMed ID: 29510730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
    Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
    Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer.
    Lin A; Zhang RL; Zhang X; He XF; Zhang JG; Yan WH
    J Cell Mol Med; 2019 Feb; 23(2):1598-1601. PubMed ID: 30370603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progression.
    Eom BW; Jo MJ; Kook MC; Ryu KW; Choi IJ; Nam BH; Kim YW; Lee JH
    Int J Cancer; 2012 Jul; 131(1):41-8. PubMed ID: 21796627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
    Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
    J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients.
    Ilm K; Kemmner W; Osterland M; Burock S; Koch G; Herrmann P; Schlag PM; Stein U
    Mol Cancer; 2015 Feb; 14():38. PubMed ID: 25742883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of metastasis-associated in colon cancer-1 in different stages of epithelial ovarian cancer].
    Zhang RT; Ren F; Shi HR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Feb; 36(1):47-51. PubMed ID: 24581128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
    Nitsche U; Rosenberg R; Balmert A; Schuster T; Slotta-Huspenina J; Herrmann P; Bader FG; Friess H; Schlag PM; Stein U; Janssen KP
    Ann Surg; 2012 Nov; 256(5):763-71; discussion 771. PubMed ID: 23095620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
    Koelzer VH; Herrmann P; Zlobec I; Karamitopoulou E; Lugli A; Stein U
    BMC Cancer; 2015 Mar; 15():160. PubMed ID: 25884643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
    Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
    Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
    Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
    Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.